Fusidic acid
Sold as Fucidin, Fucithalmic
(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-Acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
Drag to rotate. Structure from PubChem CID 3000226.
Background
Registration
- Applicants
- 2
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock ingram limited | Fucidin | cream | Q0128 | Not determined | None |
| Pharmaco Distribution (Pty) Ltd | Fucithalmic | Not stated | W0196 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fucidin cream EACH GRAM CONTAINS FUSIDIC ACID 20 mg | Cream | Q0128Q/20.1.6/0128 | Registered | Not determined | None |
| Fucithalmic EACH 1 g CONTAINS FUSIDIC ACID HEMIHYDRATE EQUIVALENT TO 10 mg ANHYDROUS FUSIDIC ACID | Not listed | W0196W/15.1/196 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Fusidic acid
- except when intended for topical application.
Consolidated Schedules 06 July 2026, line 6480
S2: Fusidic acid
- when intended for topical application.
Consolidated Schedules 06 July 2026, line 2056
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.